MMR vaccine effectiveness in an outbreak that involved day-care and primary schools

Vaccine. 2011 Oct 19;29(45):8024-31. doi: 10.1016/j.vaccine.2011.08.056. Epub 2011 Sep 3.

Abstract

Objective: In 2006, a large measles outbreak occurred in Catalonia (Spain), where the immunization schedule included two doses of MMR vaccine at 15 months and 4 years. The aim of this study was to investigate the vaccine effectiveness (VE) of MMR in children attending day-care and pre-school centres and to estimate the number of cases that would have been avoided by administering the first dose of MMR at 12 months.

Methods: A retrospective cohort study was carried out between October 2006 and January 2007 in day-care and pre-school centres with confirmed measles cases. VE was calculated in children aged ≥15 months without previous measles infection. Cases avoided by advancing the first dose of MMR to 12 months were estimated by calculating the basic and effective reproduction number in centres where transmission outside the class was observed.

Results: Fifteen centres and 1394 children were included. There were 77 confirmed cases (attack rate=5.5%). Vaccination coverage of the 1121 children aged ≥15 months was 91.6% and VE was 96% (95%CI 89-98%). There were 33 (41%) cases in the 81 children aged 12-14 months. Advancing the first dose to 12 months would have prevented 74 cases (91.5%) and lowered the attack rate from 41% to 8.6%.

Conclusions: Over 90% of cases in children aged 12-14 months would have been avoided by MMR administration at 12 rather than 15 months. We strongly recommend advancing the first dose of MMR to 12 months in order to reduce the risk of measles outbreaks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Basic Reproduction Number
  • Child
  • Child Day Care Centers
  • Child, Preschool
  • Cohort Studies
  • Disease Outbreaks*
  • Female
  • Humans
  • Infant
  • Male
  • Measles / epidemiology*
  • Measles / prevention & control*
  • Measles / transmission
  • Measles-Mumps-Rubella Vaccine / administration & dosage*
  • Measles-Mumps-Rubella Vaccine / immunology*
  • Retrospective Studies
  • Schools
  • Spain / epidemiology

Substances

  • Measles-Mumps-Rubella Vaccine